OAC
IRD

OMERS Administration Corp’s Opus Genetics IRD Stock Holding History

OMERS Administration Corp’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-41,600
Closed -$189K – 1166
2026
Q1 		$189K Sell
41,600
-46,300
-53% -$160K ﹤0.01% 928
2025
Q4 		$177K Buy
+87,900
New +$178K ﹤0.01% 925

Other funds holding IRD

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

OMERS Administration Corp's IRD Position: Q2 2026 in Review

OMERS Administration Corp sold out of Opus Genetics (IRD) in Q2 2026, closing a stake of 41,600 shares — an estimated $189K sold.

OMERS Administration Corp first reported a position in IRD in Q4 2025 and held it in 2 quarters. The position peaked at $189K in Q1 2026. 103 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • OMERS Administration Corp reported no remaining Opus Genetics position as of Q2 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 41,600 Opus Genetics shares in Q2 2026, an estimated $189K.
  • OMERS Administration Corp first reported a position in Opus Genetics in Q4 2025 and held it in 2 quarters.
  • OMERS Administration Corp's Opus Genetics position peaked at $189K in Q1 2026.
  • 103 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.